OPGN (OpGen Corp) קפיטליזציית שוק

OpGen, Inc. (OPGN) develops molecular systems for detecting therapy-resistant bacteria, targeting inpatient facilities. The company is currently undergoing a restructuring phase in an effort to maintain market share and achieve financial stability. This price chart on GURU.Markets recorded a value of 0.02, reflecting the asset's price action. The business relies on the implementation of rapid analysis tools that help physicians promptly select appropriate medications.

Stable laboratory utilization at OpGen, Inc. and the modernization of calibration lines directly impact the asset's investment attractiveness. This metric is calculated as the product of the current share price and the total number of issued securities. By analyzing the business's market capitalization, an investor assesses the aggregate value of all ownership rights in real-time. This chart reflects the market consensus regarding the company's fundamental value. Growth in this indicator confirms capital confidence in the business's technological development.